Medical Professionals Reference (MPR)FDA Clears Smart Toilet Seat for Heart Health Monitoring

The FDA has granted clearance for Casana’s Heart Seat™ toilet seat to be used in homes for monitoring heart rate and oxygen saturation (SpO2) in adults aged 22 and above, weighing between 90 and 350 pounds. The toilet seat is equipped with sensors that can measure these vital signs and transmit the data to the Casana Cloud automatically. Healthcare providers can then access the data generated by three sensors: a ballistocardiogram, which measures heart mechanical activity; an electrocardiogram, which measures heart electrical activity; and a photoplethysmogram, which detects blood volume changes. A study assessing the accuracy of the seat demonstrated consistent measurements of blood pressure, stroke volume, and blood oxygenation compared to a hospital-grade vital signs monitor. Casana intends to conduct further testing and plans to submit an application to the FDA this year to include additional clinical measurements, such as blood pressure monitoring. The Heart Seat is expected to be available by the end of 2023.